Le Lézard
Classified in: Health, Business, Covid-19 virus
Subjects: SVY, AVO

Despite improvements, over half of physicians continue to have issues accessing personal protective equipment (PPE)


CMA physician survey also highlights concerns about availability of flu vaccine and physicians' capacity to provide it, with demand exceeding supply

OTTAWA, ON, Sept. 29, 2020 /CNW/ - The Canadian Medical Association (CMA) is concerned about continued challenges physicians are experiencing accessing appropriate personal protective equipment (PPE) following results of the third membership survey since the pandemic started.

The latest survey, conducted at the end of the summer, indicates that while there have been improvements in the supply and distribution of PPE, 54% of physicians continue to encounter challenges when trying to acquire it.

"We continue to see outbreaks throughout the country and with resurgences of COVID-19 now before us, it's imperative that governments ensure our front-line workers are protected, not only in hospital settings but also in community practice settings, as they form our first line of defence against this pandemic," says Dr. Ann Collins, CMA president.

Upcoming challenges
Physicians expressed further concerns in the survey about the availability of PPE and delays in delivery. In fact, 68% of respondents worry that suppliers will not have sufficient stocks of PPE, 62% expect orders to be delayed and more than half of respondents worry global demand will hinder Canada's ability to secure a sufficient supply of PPE.

Impact of upcoming influenza season
More than 86% of physicians who responded to the survey are concerned that the influenza season will put additional strain on the health care system. Of physicians who administer the flu vaccine in their practice, 85% indicated that the system needs to build additional capacity to accommodate increased demand for influenza vaccinations this year, with 50% saying they will not be able to secure enough vaccine doses to meet patient demand.

"Immunization for influenza is more important than ever this year. We need to avoid a possible twin epidemic of flu and COVID-19 as it can be devastating to patients and our ability to sustain health care delivery," adds Dr. Collins. "We need to focus on greater funding and resourcing of public health to support mass vaccination efforts."

The survey was conducted between Aug. 19 and 24, 2020, by the CMA, with 1,459 physician members responding.

About the CMA
Since 1867, the Canadian Medical Association has been the national voice of Canada's medical profession. We work with physicians, residents and medical students on issues that matter to the profession and the health of Canadians. We advocate for policy and programs that drive meaningful change for physicians and their patients.

SOURCE Canadian Medical Association


These press releases may also interest you

at 20:31
Fitness International, LLC opened a new Club Studio location in Kingwood, Texas. The new 40,000 square foot club features five innovative boutique fitness studios that were carefully curated to create a unique experience, along with recovery services...

at 19:35
Mirum Pharmaceuticals, Inc. today announced that on May 10, 2024, the Compensation Committee of Mirum's Board of Directors granted inducement awards consisting of non-qualified stock options to purchase 38,600 shares of common stock and 19,300...

at 19:00
Evolus, Inc. , a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today reported the grant of non-qualified stock options to purchase an aggregate of 10,990 shares of Evolus and an aggregate of 42,759...

at 18:36
Inhibrx, Inc. ("Inhibrx," or the "Company") today announced that in connection with the previously announced distribution by the Company of 92% of shares of common stock of its subsidiary Inhibrx Biosciences, Inc. ("SpinCo") to holders of shares of...

at 17:55
Asia Green Biotechnology Corp. ("Asia Green" or the "Company") announces that, further to its news releases dated April 17, 2024, April 26, 2024, and May 8, 2024, the Management Cease Trade Order ("MCTO") issued by the...

at 17:53
The following statement is being issued by Rice Harbut Elliott LLP regarding the Ruckman v. Biotrade Canada Ltd. et al. lawsuit: All persons in Canada who purchased or ingested U-Dream on or after August 18, 2014 (the "Class" or "Class Members")...



News published on and distributed by: